Evaluation and validation of a real-time PCR assay for detection and quantitation of human adenovirus 14 from clinical samples.

In 2007, the Centers for Disease Control and Prevention (CDC) reported that Human adenovirus type 14 (HAdV-14) infected 106 military personnel and was responsible for the death of one U.S. soldier at Lackland Air Force Base in Texas. Identification of the responsible adenovirus, which had not previo...

Full description

Bibliographic Details
Main Authors: David Metzgar, Greg Skochko, Carl Gibbins, Nolan Hudson, Lisa Lott, Morris S Jones
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2738968?pdf=render
_version_ 1818611091963379712
author David Metzgar
Greg Skochko
Carl Gibbins
Nolan Hudson
Lisa Lott
Morris S Jones
author_facet David Metzgar
Greg Skochko
Carl Gibbins
Nolan Hudson
Lisa Lott
Morris S Jones
author_sort David Metzgar
collection DOAJ
description In 2007, the Centers for Disease Control and Prevention (CDC) reported that Human adenovirus type 14 (HAdV-14) infected 106 military personnel and was responsible for the death of one U.S. soldier at Lackland Air Force Base in Texas. Identification of the responsible adenovirus, which had not previously been seen in North America and for which rapid diagnostic tools were unavailable, required retrospective analysis at reference laboratories. Initial quarantine measures were also reliant on relatively slow traditional PCR analysis at other locations. To address this problem, we developed a real-time PCR assay that detects a 225 base pair sequence in the HAdV-14a hexon gene. Fifty-one oropharyngeal swab specimens from the Naval Health Research Center, San Diego, CA and Advanced Diagnostic Laboratory, Lackland AFB, TX were used to validate the new assay. The described assay detected eight of eight and 19 of 19 confirmed HAdV-14a clinical isolates in two separate cohorts from respiratory disease outbreaks. The real-time PCR assay had a wide dynamic range, detecting from 10(2) to 10(7) copies of genomic DNA per reaction. The assay did not cross-react with other adenoviruses, influenza, respiratory syncytial virus, or common respiratory tract bacteria. The described assay is easy to use, sensitive and specific for HAdV-14a in clinical throat swab specimens, and very rapid since turnaround time is less than four hours to obtain an answer.
first_indexed 2024-12-16T15:24:49Z
format Article
id doaj.art-d384b419a74545efb6d8bdb65c01b77c
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-16T15:24:49Z
publishDate 2009-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-d384b419a74545efb6d8bdb65c01b77c2022-12-21T22:26:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032009-01-0149e708110.1371/journal.pone.0007081Evaluation and validation of a real-time PCR assay for detection and quantitation of human adenovirus 14 from clinical samples.David MetzgarGreg SkochkoCarl GibbinsNolan HudsonLisa LottMorris S JonesIn 2007, the Centers for Disease Control and Prevention (CDC) reported that Human adenovirus type 14 (HAdV-14) infected 106 military personnel and was responsible for the death of one U.S. soldier at Lackland Air Force Base in Texas. Identification of the responsible adenovirus, which had not previously been seen in North America and for which rapid diagnostic tools were unavailable, required retrospective analysis at reference laboratories. Initial quarantine measures were also reliant on relatively slow traditional PCR analysis at other locations. To address this problem, we developed a real-time PCR assay that detects a 225 base pair sequence in the HAdV-14a hexon gene. Fifty-one oropharyngeal swab specimens from the Naval Health Research Center, San Diego, CA and Advanced Diagnostic Laboratory, Lackland AFB, TX were used to validate the new assay. The described assay detected eight of eight and 19 of 19 confirmed HAdV-14a clinical isolates in two separate cohorts from respiratory disease outbreaks. The real-time PCR assay had a wide dynamic range, detecting from 10(2) to 10(7) copies of genomic DNA per reaction. The assay did not cross-react with other adenoviruses, influenza, respiratory syncytial virus, or common respiratory tract bacteria. The described assay is easy to use, sensitive and specific for HAdV-14a in clinical throat swab specimens, and very rapid since turnaround time is less than four hours to obtain an answer.http://europepmc.org/articles/PMC2738968?pdf=render
spellingShingle David Metzgar
Greg Skochko
Carl Gibbins
Nolan Hudson
Lisa Lott
Morris S Jones
Evaluation and validation of a real-time PCR assay for detection and quantitation of human adenovirus 14 from clinical samples.
PLoS ONE
title Evaluation and validation of a real-time PCR assay for detection and quantitation of human adenovirus 14 from clinical samples.
title_full Evaluation and validation of a real-time PCR assay for detection and quantitation of human adenovirus 14 from clinical samples.
title_fullStr Evaluation and validation of a real-time PCR assay for detection and quantitation of human adenovirus 14 from clinical samples.
title_full_unstemmed Evaluation and validation of a real-time PCR assay for detection and quantitation of human adenovirus 14 from clinical samples.
title_short Evaluation and validation of a real-time PCR assay for detection and quantitation of human adenovirus 14 from clinical samples.
title_sort evaluation and validation of a real time pcr assay for detection and quantitation of human adenovirus 14 from clinical samples
url http://europepmc.org/articles/PMC2738968?pdf=render
work_keys_str_mv AT davidmetzgar evaluationandvalidationofarealtimepcrassayfordetectionandquantitationofhumanadenovirus14fromclinicalsamples
AT gregskochko evaluationandvalidationofarealtimepcrassayfordetectionandquantitationofhumanadenovirus14fromclinicalsamples
AT carlgibbins evaluationandvalidationofarealtimepcrassayfordetectionandquantitationofhumanadenovirus14fromclinicalsamples
AT nolanhudson evaluationandvalidationofarealtimepcrassayfordetectionandquantitationofhumanadenovirus14fromclinicalsamples
AT lisalott evaluationandvalidationofarealtimepcrassayfordetectionandquantitationofhumanadenovirus14fromclinicalsamples
AT morrissjones evaluationandvalidationofarealtimepcrassayfordetectionandquantitationofhumanadenovirus14fromclinicalsamples